昭衍新药授予316万股限制性股票 激励对象280人

财中社
Jun 05

6月4日,昭衍新药(603127/06127)发布公告,公司授予激励对象316万股A股限制性股票,授予价格为19.17元/股,激励对象人数为280人。  2026年一季度,昭衍新药实现收入3.16亿元,归母净利润2.38亿元。(文章来源:财中社)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10